Expertise in
6
conditions

Hawk G. Kim

Incheon, KR 
Expertise in
6
conditions
Incheon, KR 

Overview

Hawk Kim practices practicing medicine in Incheon, Republic of Korea.

Mr. Kim is highly rated in 6 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Aplastic Anemia, Leukemia, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 96 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

Incheon, Republic of Korea
Other Locations
Seoul, Republic of Korea
Ulsan, Republic of Korea
Yangsan, Republic of Korea
Daegu, Republic of Korea

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase 1/2 Study of REGN7257 (Anti-Interleukin 2 Receptor Subunit Gamma [IL2RG] Monoclonal Antibody) in Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
A Phase 1/2 Study of REGN7257 (Anti-Interleukin 2 Receptor Subunit Gamma [IL2RG] Monoclonal Antibody) in Patients With Severe Aplastic Anemia That Is Refractory to or Relapsed on Immunosuppressive Therapy
Enrollment Status: Terminated
Publish Date: June 22, 2026
Intervention Type: Drug
Study Drug: REGN7257
Study Phase: Phase 1
Phase 2 Study of Autologous Hematopoietic Cell Transplantation for Core-binding Factor Positive Acute Myeloid Leukemia in the First Complete Remission
Phase 2 Study of Autologous Hematopoietic Cell Transplantation for Core-binding Factor Positive Acute Myeloid Leukemia in the First Complete Remission
Enrollment Status: Completed
Publish Date: March 17, 2025
Intervention Type: Procedure
Study Phase: Not Applicable
A Phase 2, Multicenter, Non-Randomized, Open-Label Study of RVT-1401 for the Treatment of Patients With Warm Autoimmune Hemolytic Anemia
A Phase 2, Multicenter, Non-Randomized, Open-Label Study of RVT-1401 for the Treatment of Patients With Warm Autoimmune Hemolytic Anemia
Enrollment Status: Terminated
Publish Date: July 28, 2022
Intervention Type: Drug
Study Phase: Phase 2
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Phase 2 Study Evaluating the Efficacy of Rituximab Plus Modified VPDL for Newly Diagnosed CD20-Positive Adult Acute Lymphoblastic Leukemia
Enrollment Status: Unknown
Publish Date: July 24, 2018
Intervention Type: Drug
Study Drugs: Rituximab, Modified VPDL
Study Phase: Phase 2
View 3 Less Clinical Trials

96 Total Publications

Asciminib as first-line therapy in chronic myeloid leukemia: a systematic review.
Asciminib as first-line therapy in chronic myeloid leukemia: a systematic review.
Journal: Blood research
Published: March 23, 2026

Frequently Asked Questions about Hawk G. Kim

Is Hawk G. Kim a top-rated expert for Chronic Myelogenous Leukemia (CML)?

MediFind is an objective health platform that identifies experts based on real-world data. Hawk G. Kim is classified as an Advanced expert for Chronic Myelogenous Leukemia (CML), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Hawk G. Kim participate in research or clinical trials?

Yes. Hawk G. Kim has published 96 articles and abstracts on conditions like Chronic Myelogenous Leukemia (CML). You can view a list of Hawk G. Kim's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kim's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile